ADM and hereditary hemorrhagic telangiectasia: Recently, we reported that HHT patients present higher serum levels of the cardiovascular regulatory peptide adrenomedullin (AM) than healthy volunteers, and that immunoreactivity for this peptide accumulates in the abnormal blood vessels of the telangiectases [10].